SpringWorks Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SpringWorks Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • SpringWorks Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.36M, a 5.93% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.36M -$401K -5.93% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.82M -$785K -11.9% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.14M +$1.45M +30.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $6.47M +$1.56M +31.7% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $6.76M +$1.63M +31.8% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $6.6M +$1.25M +23.3% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $4.7M +$3.69M +365% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $4.91M +$3.67M +295% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.13M +$3.66M +249% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.36M +$3.66M +216% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.01M -$1.87M -64.9% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.24M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.47M Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.7M Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $2.88M $0 0% Dec 31, 2020 10-K 2023-02-28
Q4 2019 $2.88M Jan 1, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.